company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,31115000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31115000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6023000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3704000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1912000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15893000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,58647000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,58647000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4674000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-40000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,63000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-339000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4990000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4990000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-255000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-19520000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,97000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-19678000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-19678000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33979000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,23777000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23777000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6181000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3771000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1382000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1848000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,36959000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,36959000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7295000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-49000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,62000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-412000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7694000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7694000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-245000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2312000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17112000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14555000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14555000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,43820000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,597000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q4,2009-10-01,2009-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,41703000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,32286000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32286000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5754000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3839000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2016000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18471000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,62366000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,62366000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6155000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9084000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,66000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-441000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15614000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15614000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-86467000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2696000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,134000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-89029000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-89029000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-42277000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,34362000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34362000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5766000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3896000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3634000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1336000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,48994000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,48994000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6541000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-58000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,59000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-480000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7020000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7020000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5219000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2860000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,959000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7120000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7120000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,34854000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,38763000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,38763000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5814000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3855000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1601000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7736000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,57769000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,57769000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6965000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-38000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,281000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-436000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7158000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7158000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24366000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-391000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-31720000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,156000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-56280000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-56280000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5669000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,39990000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39990000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5779000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3497000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2927000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15490000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,36703000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,36703000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7908000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-53000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,263000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1247000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8945000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8945000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-58904000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-410000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-2696000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,179000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-61831000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-61831000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-34073000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,566000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,57259000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,45992000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45992000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5831000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2223000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1566000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2410000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,58022000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,58022000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4379000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-30000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,64000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-279000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4624000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4624000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-46570000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-49805000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-11544000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,435000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,217000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-107267000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-107267000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-53869000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,40384000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40384000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5805000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1921000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4026000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12204000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,39932000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,39932000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7605000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-102000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,107000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-80000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7680000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7680000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19001000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2292000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-11405000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,460000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-55464000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-87702000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-87702000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-55450000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,45109000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45109000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5738000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1697000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7747000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11416000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,48875000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,48875000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6219000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-21045000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,512000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-418000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27170000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27170000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-165893000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3398000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-11658000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,313000000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,298000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-161594000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-29245000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-29245000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7540000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,53159000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,53159000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4138000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,57297000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,57297000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11724000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,2136000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,217000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3173000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12544000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12544000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-119114000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-6330000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-11671000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,104426000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,246000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-32442000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-32442000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12311000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2308000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,74724000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,53930000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,53930000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5883000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-187000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5837000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,53789000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,53789000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7297000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-147000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,136000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-679000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7987000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7987000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-26874000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-12889000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-13334000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,500000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-51597000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-51597000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5795000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,52951000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52951000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5077000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8964000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19887000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,47105000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,47105000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7597000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-537000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,243000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1124000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6767000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6767000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21877000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-37271000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-13290000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,29000000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2971000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-40467000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-40467000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-129000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,54549000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,54549000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6459000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3450000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13202000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51256000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51256000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9260000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-412000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,120000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-439000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9991000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9991000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4586000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-33190000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-13252000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,11000000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,13000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-40015000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-40015000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1250000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,55182000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55182000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5498000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,479000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4781000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,19112000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,85052000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,85052000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6997000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1108000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-322000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,168000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9259000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9259000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-59016000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-92382000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-13374000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,80000000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1800000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1747000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-81225000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-81225000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5432000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,7352000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,85660000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,56732000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56732000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6025000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3509000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1992000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,68258000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,68258000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8443000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-847000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,377000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-654000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9567000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9567000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18013000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-47745000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-14820000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,25000000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,588000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-54990000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-54990000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3701000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,59942000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,59942000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5964000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4791000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2454000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,68243000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,68243000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9492000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1382000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,320000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-873000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11427000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11427000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17012000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-52671000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-14688000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,26000000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1848000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-56523000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-56523000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,293000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,61804000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61804000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6753000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4590000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1000000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,74147000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,74147000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9053000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-854000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,155000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1026000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10828000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10828000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-16010000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-55855000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-14617000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,22000000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,147000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-64335000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-64335000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1016000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,64716000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64716000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6729000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,480000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2761000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12803000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,87489000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,87489000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8428000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-447000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,184000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2637000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11376000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11376000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-83011000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-70945000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-14517000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,94000000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1244000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-73229000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-73229000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2884000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,8869000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,57001000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,61153000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61153000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6633000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4715000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6877000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,65624000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,65624000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7668000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,227000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3034000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10475000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10475000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28011000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-46811000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-22491000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,40000000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,329000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-56984000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-56984000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1835000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,64096000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64096000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6318000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5312000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10117000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,65609000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,65609000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12119000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-304000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,377000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1032000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13078000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13078000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9033000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-78483000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-22840000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,63000000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1120000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-46236000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-46236000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6295000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,66650000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,66650000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6845000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5815000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4884000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,74426000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,74426000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7837000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-449000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,494000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-616000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8408000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8408000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21167000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-85108000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-22215000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,57000000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1231000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-70259000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-70259000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4241000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,31042000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31042000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6566000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5842000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,36079000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,79529000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,79529000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6869000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-186000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,726000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-647000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6976000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6976000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18125000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-69633000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-23940000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,35000000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-68000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-76766000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-76766000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4213000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,34702000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34702000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6930000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5393000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-262000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,46763000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,46763000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5441000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-326000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,107000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-14741000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20401000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20401000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9154000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-45950000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-23568000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,56000000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-247000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-22919000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-22919000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3443000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,33594000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33594000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6910000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8178000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5204000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,43478000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,43478000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5966000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-990000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,360000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-646000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7242000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7242000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-22753000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-23672000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-23425000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,29000000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,495000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-40355000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-40355000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4119000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15594000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15594000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7051000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10408000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16277000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,49330000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,49330000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4521000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-13732000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,127000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,13091000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5035000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5035000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-90011000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-20454000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24442000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,95000000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-355000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-40262000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-40262000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4033000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,12313000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,35523000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15117000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15117000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6847000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3560000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,20573000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,46097000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,46097000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2858000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-36000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,408000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-532000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3018000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3018000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-37838000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-696000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-23306000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13000000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-68000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-48908000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-48908000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5829000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,16535000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16535000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6751000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5360000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-929000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,27717000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,27717000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2444000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-63000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,131000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-438000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2814000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2814000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-220838000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-416000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-23531000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,21000000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,196995000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-26790000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-26790000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1887000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,16838000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16838000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6724000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6111000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5197000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,34870000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,34870000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2438000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-106000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,166000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2287000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4665000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4665000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-31550000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1045000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24257000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,29000000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,88000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-27764000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-27764000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2441000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15369000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15369000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6550000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8140000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6856000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,23203000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,23203000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3616000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1385000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,35000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,742000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4224000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4224000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-26018000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5004000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-25437000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,36000000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,197202000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-198177000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-21434000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-21434000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2455000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,11248000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12181000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,17682000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17682000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6304000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7240000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1465000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,29761000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,29761000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6449000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-102000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,324000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-399000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6626000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6626000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-49000000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1273000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24284000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,51000000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-23557000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-23557000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-422000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,102637000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,2111000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,100526000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6038000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-73070000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12422000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45916000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45916000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4511000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,282000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,59000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1133000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5303000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5303000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-41026000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-8712000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24255000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,34000000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-39993000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-39993000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,620000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,10527000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,24314000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,23577000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23577000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5818000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6606000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12908000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,23093000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,23093000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4443000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,280000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-454000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4617000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4617000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-29000000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3310000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24322000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,37000000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-19632000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-19632000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1156000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,4149000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4056000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,24805000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24805000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5868000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5057000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8740000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,26990000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,26990000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7472000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-81000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1144000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8697000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8697000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-29553000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-650000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24313000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,36000000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-18516000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-18516000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-223000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1423000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7288000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48286000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22871000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-10040000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20521000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9509000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,23843000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,23843000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,11319000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,71000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-62941000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51551000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51551000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-23092000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-817000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24304000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,77000000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28787000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28787000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1079000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4196000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10477000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,159540000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-58000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,88441000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21441000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-76411000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4430000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,37901000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,37901000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21145000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-47314000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,612000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,62073000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5774000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5774000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34125000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2674000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24312000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,28000000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-33111000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-33111000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-984000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1731000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10107000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,27457000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,8808000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18908000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5786000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3899000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3715000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17080000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17080000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7047000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,440000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,19311000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-445000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12259000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12259000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36000000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-604000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-24395000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,31000000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-29999000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-29999000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-660000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1991000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5793000.0
